Access Pharmaceuticals Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 06 | Dec 05 | Dec 04 | |
|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.6 |
| Cost of Goods Sold | -- | -- | 0.2 |
| Gross Profit | -- | -- | 0.3 |
| Gross Profit Margin | 0.0% | 0.0% | 56.4% |
| SG&A Expense | (1.9) | 8.1 | 8.3 |
| Depreciation & Amortization | 7.1 | 1.6 | 1.1 |
| Operating Income | (5.2) | (9.6) | (9.1) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | (0.8) | 0.1 | 0.2 |
| Nonoperating Expenses | 7.4 | 2.1 | 1.4 |
| Income Before Taxes | (13.4) | (11.6) | (10.2) |
| Income Taxes | (0.2) | (4.1) | -- |
| Net Income After Taxes | (13.3) | (7.5) | (10.2) |
| Continuing Operations | (13.3) | (7.6) | (10.2) |
| Discontinued Operations | 0.4 | 5.9 | -- |
| Total Operations | (12.9) | (1.7) | (10.2) |
| Total Net Income | (12.9) | (1.7) | (10.2) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (3.65) | (0.50) | (3.40) |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
